litlas
Log inCreate account

Jan C. Buckner

Active 1993–2024

108
Papers
26,185
Citations
87
h-index
108
i10-index

Citations

Citations per year for Jan C. Buckner1993: 1 citations1994: 3 citations1995: 1 citations1996: 4 citations1997: 17 citations1998: 16 citations1999: 14 citations2000: 27 citations2001: 36 citations2002: 32 citations2003: 74 citations2004: 69 citations2005: 88 citations2006: 145 citations2007: 151 citations2008: 173 citations2009: 198 citations2010: 202 citations2011: 203 citations2012: 190 citations2013: 149 citations2014: 179 citations2015: 232 citations2016: 201 citations2017: 325 citations2018: 230 citations2019: 859 citations2020: 953 citations2021: 781 citations2022: 714 citations2023: 451 citations2024: 663 citations2025: 288 citations2026: 10 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,941 citing papers, 31.7% of this breakdownChina: 810 citing papers, 8.7% of this breakdownGermany: 589 citing papers, 6.3% of this breakdownUnited Kingdom: 444 citing papers, 4.8% of this breakdownItaly: 413 citing papers, 4.5% of this breakdownCanada: 410 citing papers, 4.4% of this breakdownFrance: 378 citing papers, 4.1% of this breakdownNetherlands: 335 citing papers, 3.6% of this breakdownSwitzerland: 273 citing papers, 2.9% of this breakdownJapan: 238 citing papers, 2.6% of this breakdownAustralia: 208 citing papers, 2.2% of this breakdownSpain: 189 citing papers, 2% of this breakdown
0%31.7%Other 22.2%

Institutions

Fields

  • Medicine72.7%
  • Biochemistry, Genetics and Molecular Biology16.8%
  • Neuroscience2.6%
  • Immunology and Microbiology2.2%
  • Engineering1.2%
  • Materials Science1.1%
  • Other3.4%

Topics

  • Glioma Diagnosis and Treatment17.9%
  • Brain Metastases and Treatment8.3%
  • Radiomics and Machine Learning in Medical Imaging3.2%
  • Meningioma and schwannoma management2.9%
  • Lung Cancer Research Studies1.8%
  • Cancer Genomics and Diagnostics1.6%
  • Other64.3%

Coauthors

All papers

Open in search
  1. Is the blood–brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data

    Authors: Jann N. Sarkaria, Leland Hu, Ian F. Parney, Deanna Pafundi, Debra H. Brinkmann, Nadia N. Laack, Caterina Giannini, Terence Burns, Sani H. Kizilbash, Janice K. Laramy, Kristin R. Swanson, Timothy J. Kaufmann, Paul D. Brown, Nathalie Y.R. Agar, Evanthia Galanis, Jan C. Buckner, William F. Elmquist - Neuro-Oncology 2017 cited by 699

  2. Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases

    Authors: Paul D. Brown, Kurt A. Jaeckle, Karla V. Ballman, Elana Farace, Jane H. Cerhan, S. Keith Anderson, Xiomara W. Carrero, Fred G. Barker, Richard L. Deming, Stuart H. Burri, Cynthia Ménard, Caroline Chung, Volker W. Stieber, Bruce E. Pollock, Evanthia Galanis, Jan C. Buckner, Anthony L. Asher - JAMA 2016 cited by 1,661

  3. Glioma Groups Based on 1p/19q,IDH, andTERTPromoter Mutations in Tumors

    Authors: Jeanette E. Eckel‐Passow, Daniel H. Lachance, Annette M Molinaro, Kyle M. Walsh, Paul A. Decker, Hugues Sicotte, Melike Pekmezci, Terri Rice, Matt Kosel, Ivan Smirnov, Gobinda Sarkar, Alissa Caron, Thomas M. Kollmeyer, Corinne Praska, Anisha R. Chada, Chandralekha Halder, Helen M. Hansen, Lucie McCoy, Paige M. Bracci, Roxanne Marshall, Shichun Zheng, Gerald F. Reis, Alexander R. Pico, Brian Patrick O’Neill, Jan C. Buckner, Caterina Giannini, Jason T. Huse, Arie Perry, Tarık Tihan, Mitchel S. Berger, Susan M. Chang, Michael D. Prados, Joseph L. Wiemels, John K. Wiencke, Margaret Wrensch, Robert B. Jenkins - New England Journal of Medicine 2015 cited by 1,984

  4. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial

    Authors: Paul D. Brown, Karla V. Ballman, Jane H. Cerhan, S. Keith Anderson, Xiomara W. Carrero, Anthony Whitton, Jeffrey Greenspoon, Ian F. Parney, Nadia N. Laack, Jonathan B. Ashman, Jean-Paul Bahary, Costas G. Hadjipanayis, James J. Urbanic, Fred G. Barker, Elana Farace, Deepak Khuntia, Caterina Giannini, Jan C. Buckner, Evanthia Galanis, David Roberge - The Lancet Oncology 2017 cited by 1,192

  5. Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma

    Authors: Jan C. Buckner, Edward G. Shaw, Stephanie L. Pugh, Arnab Chakravarti, Mark R. Gilbert, Geoffrey Barger, Stephen W. Coons, Peter E. Ricci, Dennis E. Bullard, Paul D. Brown, K. Stelzer, David Brachman, John H. Suh, Christopher J. Schultz, Jean-Paul Bahary, Barbara J. Fisher, Harold Kim, Albert Murtha, Erica H. Bell, Minhee Won, Minesh P. Mehta, Walter J. Curran - New England Journal of Medicine 2016 cited by 1,044

  6. Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402

    Authors: Gregory Cairncross, Meihua Wang, Edward Shaw, Robert B. Jenkins, David Brachman, Jan C. Buckner, Karen Fink, Luís Souhami, Normand Laperrière, Walter Curran, Minesh P. Mehta - Journal of Clinical Oncology 2012 cited by 1,163

  7. Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial

    Authors: Evanthia Galanis, Katharine Dooley, S. Keith Anderson, Cheyne Kurokawa, Xiomara W. Carrero, Joon H. Uhm, Mark J. Federspiel, Alexey A. Leontovich, Ileana Aderca, Kimberly Viker, Julie E. Hammack, Randolph S. Marks, Steven I. Robinson, Derek R. Johnson, Timothy J. Kaufmann, Jan C. Buckner, Daniel H. Lachance, Terry C. Burns, Caterina Giannini, Aditya Raghunathan, Ianko Iankov, Ian F. Parney - Nature Communications 2024 cited by 68

  8. Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes

    Authors: Michael J. Haller, Desmond Schatz, Jay S. Skyler, Jeffrey P. Krischer, Brian N. Bundy, Jessica Miller, Mark A. Atkinson, Dorothy J. Becker, David A. Baidal, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Kevan C. Herold, Jennifer B. Marks, Antoinette Moran, Henry Rodriguez, William E. Russell, Darrell M. Wilson, Carla J. Greenbaum, Type 1 Diabetes TrialNet ATG-GCSF Study Group, Carla J. Greenbaum, Mark A. Atkinson, David A. Baidal, M. Battaglia, Dorothy Becker, P. J. Bingley, Emanuele Bosi, Jan C. Buckner, Mark A. Clements, Peter G. Colman, Linda A. DiMeglio, Carmella Evans‐Molina, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Kevan C. Herold, Mikael Knip, J. Krischer, Åke Lernmark, W. Moore, Antoinette Moran, Andrew J. Muir, J. Palmer, Mark Peakman, Louis H. Philipson, Philip Raskin, María J. Redondo, Henry Rodriguez, W. J. Russell, Lisa M. Spain, Desmond Schatz, Jay M. Sosenko, Diane K. Wherrett, Darrell M. Wilson, William E. Winter, Anette‐Gabriele Ziegler, Mark S. Anderson, Peter A. Antinozzi, Christophe Benoıst, J.J. Blum, Kasia Bourcier, Peter Chase, Michael Clare‐Salzler, Raphael Clynes, Catherine C. Cowie, George S. Eisenbarth, C. Garrison Fathman, Gilman D. Grave, L. Harrison, Bernhard J. Hering, Richard A. Insel, Sabine D. Jordan, Francine Kaufman, Tom Kay, Norma S. Kenyon, R. Klines, John M. Lachin, Ellen Leschek, Jeff Mahon, Jennifer B. Marks, Roshanak Monzavi, Kirsti Näntö‐Salonen, Gerald T. Nepom, Tihamer Orban, Robertson Parkman, Mark D. Pescovitz, John Peyman, A. Pugliese, John A. Ridge, Bart O. Roep, Maria Grazia Roncarolo, Peter J. Savage, Olli Simell, R S Sherwin, Mark Siegelman, Jay S. Skyler, Andrea K. Steck, James W. Thomas, Massimo Trucco and 212 more - Diabetes Care 2018 cited by 180

  9. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk

    Authors: María J. Redondo, Susan Geyer, Andrea K. Steck, Seth A. Sharp, John M. Wentworth, Michael N. Weedon, Peter A. Antinozzi, Jay M. Sosenko, Mark A. Atkinson, Alberto Pugliese, Richard A. Oram, Type 1 Diabetes TrialNet Study Group, Peter A. Antinozzi, Mark A. Atkinson, Manuela Battaglia, Dorothy J. Becker, P. J. Bingley, Emanuele Bosi, Jan C. Buckner, Peter G. Colman, Peter A. Gottlieb, Kevan C. Herold, Richard A. Insel, Tom Kay, Mikael Knip, Jennifer B. Marks, Antoinette Moran, James L. Palmer, Mark Peakman, Louis H. Philipson, Alberto Pugliese, P. Raskin, Henry Rodriguez, Bart O. Roep, William E. Russell, Desmond Schatz, Diane K. Wherrett, Darrell M. Wilson, William E. Winter, Anette‐Gabriele Ziegler, Christophe Benoıst, J.J. Blum, Peter Chase, Michael Clare‐Salzler, Raphael Clynes, George S. Eisenbarth, C. Garrison Fathman, Gilman D. Grave, Bernhard J. Hering, Francine Kaufman, Ellen Leschek, J. Mahon, Kirsti Näntö‐Salonen, Gerald T. Nepom, Tihamer Orban, Robertson Parkman, Mark D. Pescovitz, John Peyman, Maria Grazia Roncarolo, Olli Simell, Robert Sherwin, Mark Siegelman, Andrea K. Steck, James W. Thomas, Massimo Trucco, J. Richard Wagner, Carla J. Greenbaum, Katarzyna Bourcier, Richard A. Insel, Jeffrey P. Krischer, Ellen Leschek, Lisa Rafkin, Lisa M. Spain, Catherine C. Cowie, Mary A. Foulkes, Heidi Krause‐Steinrauf, John M. Lachin, Saúl Malozowski, John Peyman, J P Ridge, Peter J. Savage, Jay S. Skyler, Stephanie J. Zafonte, Norma S. Kenyon, Irene Santiago, Jay M. Sosenko, Brian N. Bundy, Michael Abbondondolo, Timothy E. Adams, Darlene Amado, Ilma Asif, Matthew Boonstra, Brian N. Bundy, Cristina Burroughs, David Cuthbertson, Mary Deemer, Christopher Eberhard, Steve Fiske, Julie Ford, Jennifer Garmeson and 1,520 more - Diabetes Care 2018 cited by 169

  10. Residual Deep Convolutional Neural Network Predicts MGMT Methylation Status

    Authors: Panagiotis Korfiatis, Timothy L. Kline, Daniel H. Lachance, Ian F. Parney, Jan C. Buckner, Bradley J. Erickson - Journal of Digital Imaging, J. Digit. Imaging 2017 cited by 201

  11. Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma

    Authors: Erica H. Bell, Jianwen Zhang, Edward G. Shaw, Jan C. Buckner, Geoffrey Barger, Dennis E. Bullard, Minesh P. Mehta, Mark R. Gilbert, Paul D. Brown, K. Stelzer, Joseph P. McElroy, Jessica L. Fleming, Cynthia Timmers, Aline Paixão Becker, Andrea L. Salavaggione, Ziyan Liu, Kenneth Aldape, David Brachman, Stanley Z. Gertler, Albert Murtha, Christopher J. Schultz, David W. Johnson, Nadia N. Laack, G.K. Hunter, Ian Crocker, Minhee Won, Arnab Chakravarti - Journal of Clinical Oncology 2020 cited by 222

  12. A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K

    Authors: J. Daniel, Evanthia Galanis, S. Keith Anderson, David Schiff, Timothy J. Kaufmann, Patrick J. Peller, Caterina Giannini, Paul D. Brown, Joon H. Uhm, Steven McGraw, Kurt A. Jaeckle, Patrick J. Flynn, Keith L. Ligon, Jan C. Buckner, Jann N. Sarkaria - Neuro-Oncology 2014 cited by 166

  13. Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02

    Authors: Evanthia Galanis, S. Keith Anderson, C. Ryan Miller, Jann N. Sarkaria, Kurt A. Jaeckle, Jan C. Buckner, Keith L. Ligon, Karla V. Ballman, Dennis F. Moore, Michael Nebozhyn, Andrey Loboda, David Schiff, Manmeet S. Ahluwalia, Eudocia Q. Lee, Elizabeth R. Gerstner, Glenn J. Lesser, Michael D. Prados, Stuart A. Grossman, Jane Cerhan, Caterina Giannini, Patrick Y. Wen - Neuro-Oncology 2017 cited by 134

  14. Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

    Authors: Evanthia Galanis, Kurt A. Jaeckle, Matthew J. Maurer, Joel M. Reid, Matthew M. Ames, James S. Hardwick, John F. Reilly, Andrey Loboda, Michael Nebozhyn, Valeria R. Fantin, Victoria M. Richon, Bernd W. Scheithauer, Caterina Giannini, Patrick J. Flynn, Dennis F. Moore, James A. Zwiebel, Jan C. Buckner - Journal of Clinical Oncology 2009 cited by 357

  15. Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074

    Authors: Joon H. Uhm, Karla V. Ballman, Wenting Wu, Caterina Giannini, John C. Krauss, Jan C. Buckner, C. David James, Bernd W. Scheithauer, Robert J. Behrens, Patrick J. Flynn, Paul Schaefer, Shaker R. Dakhill, Kurt A. Jaeckle - International Journal of Radiation Oncology*Biology*Physics 2010 cited by 186

  16. A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with Oligodendroglioma

    Authors: Robert B. Jenkins, Hilary Blair, Karla V. Ballman, Caterina Giannini, Robert M. Arusell, Mark E. Law, Heather C. Flynn, Sandra Passe, Sara J. Felten, Paul D. Brown, Edward G. Shaw, Jan C. Buckner - Cancer Research 2006 cited by 759

  17. Phase II Trial of Temsirolimus (CCI-779) in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

    Authors: Evanthia Galanis, Jan C. Buckner, Matthew J. Maurer, Jeffrey I. Kreisberg, Karla V. Ballman, Joseph Boni, Josep Maria Peralba, Robert B. Jenkins, Shaker R. Dakhil, Roscoe F. Morton, Kurt A. Jaeckle, Bernd W. Scheithauer, Janet Dancey, Manuel Hidalgo, Daniel J. Walsh - Journal of Clinical Oncology 2005 cited by 696

  18. Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH

    Authors: J. Gregory Cairncross, Meihua Wang, Robert B. Jenkins, Edward G. Shaw, Caterina Giannini, David Brachman, Jan C. Buckner, Karen Fink, Luís Souhami, Normand Laperrière, Jason T. Huse, Minesh P. Mehta, Walter J. Curran - Journal of Clinical Oncology 2014 cited by 396

  19. The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme

    Authors: Karla V. Ballman, Jan C. Buckner, Paul D. Brown, Caterina Giannini, Patrick J. Flynn, Betsy LaPlant, Kurt A. Jaeckle - Neuro-Oncology 2006 cited by 318

  20. Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis

    Authors: Joshua D. Palmer, Brett Klamer, Karla V. Ballman, Paul D. Brown, Jane H. Cerhan, S. Keith Anderson, Xiomara W. Carrero, Anthony Whitton, Jeffrey Greenspoon, Ian F. Parney, Nadia N. Laack, Jonathan B. Ashman, Jean-Paul Bahary, Costas G. Hadjipanayis, James J. Urbanic, Fred G. Barker, Elana Farace, Deepak Khuntia, Caterina Giannini, Jan C. Buckner, Evanthia Galanis, David Roberge - JAMA Oncology 2022 cited by 72

  21. A phase 1 and randomized, placebo‐controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872

    Authors: Evanthia Galanis, S. Keith Anderson, Erin Twohy, Xiomara W. Carrero, Jesse G. Dixon, David Tran, Suriya Jeyapalan, Daniel M. Anderson, Timothy J. Kaufmann, Ryan W. Feathers, Caterina Giannini, Jan C. Buckner, Panos Z. Anastasiadis, David Schiff - Cancer 2019 cited by 70

  22. PTEN Mutation, EGFR Amplification, and Outcome in Patients With Anaplastic Astrocytoma and Glioblastoma Multiforme

    Authors: Justin S. Smith, Issei Tachibana, Sandra Passe, B K Huntley, Thomas J. Borell, Nancy Iturria, Judith R. OʼFallon, Paul Schaefer, B. W. Scheithauer, C. David James, Jan C. Buckner, Robert B. Jenkins - JNCI Journal of the National Cancer Institute 2001 cited by 645

  23. Randomized Trial of Radiation Therapy Plus Procarbazine, Lomustine, and Vincristine Chemotherapy for Supratentorial Adult Low-Grade Glioma: Initial Results of RTOG 9802

    Authors: Edward G. Shaw, Meihua Wang, Stephen W. Coons, David Brachman, Jan C. Buckner, K. Stelzer, Geoffrey Barger, Paul D. Brown, Mark R. Gilbert, Minesh P. Mehta - Journal of Clinical Oncology 2012 cited by 354

  24. MRI texture features as biomarkers to predict MGMT methylation status in glioblastomas

    Authors: Panagiotis Korfiatis, Timothy L. Kline, Lucie Coufalová, Daniel H. Lachance, Ian F. Parney, Rickey E. Carter, Jan C. Buckner, Bradley J. Erickson - Medical Physics 2016 cited by 164